BRAFTOVI 75 MG Oral Capsule

RxCUI: 2049121
RxNorm name: BRAFTOVI 75 MG Oral Capsule
Display name: BRAFTOVI 75 MG Oral Capsule
Full name: BRAFTOVI 75 MG Oral Capsule
Term type: PSN
Status: DailyMed mapping
Updated: 2026-06-04 23:38:50

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
BRAFTOVI	ENCORAFENIB	Array BioPharma Inc.	235dfc38-0f0b-4037-b501-7a9f4294740c	2026-02-26	Warnings, Adverse reactions	Exact identifier rxcui: 2049121

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set ID	RxNorm string	TTY	SPL version	Label	Effective
235dfc38-0f0b-4037-b501-7a9f4294740c	BRAFTOVI 75 MG Oral Capsule	PSN	23	These highlights do not include all the information needed to use BRAFTOVI safely and effectively. See full prescribing information for BRAFTOVI. BRAFTOVI ® (encorafenib) capsules, for oral use Initial U.S. Approval: 2018	20260226
235dfc38-0f0b-4037-b501-7a9f4294740c	encorafenib 75 MG Oral Capsule [Braftovi]	SBD	23	These highlights do not include all the information needed to use BRAFTOVI safely and effectively. See full prescribing information for BRAFTOVI. BRAFTOVI ® (encorafenib) capsules, for oral use Initial U.S. Approval: 2018	20260226
235dfc38-0f0b-4037-b501-7a9f4294740c	Braftovi 75 MG Oral Capsule	SY	23	These highlights do not include all the information needed to use BRAFTOVI safely and effectively. See full prescribing information for BRAFTOVI. BRAFTOVI ® (encorafenib) capsules, for oral use Initial U.S. Approval: 2018	20260226